Max Healthcare Institute revenue and financials
₹861.00Change from previous close: −0.57%Absolute change: −₹4.95
In the fiscal year ended March 2026, Max Healthcare Institute reported revenue of ₹83.73B (+19.14% year over year). Net income was ₹14.42B, a net margin of 17.2%.
Fiscal year ending in March. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +19.14%
- FY to Mar 2026 vs FY to Mar 2025
- Net income growth
- +34.07%
- FY to Mar 2026 vs FY to Mar 2025
- Net margin
- 17.2%
- FY to Mar 2025: 15.3%
Financial data
Amounts in millions of INR; per-share values in INR; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 23,662 | 21,429 | 20,675 | 21,355 | 20,276 | 19,097 | 18,683 | 17,075 | 15,430 | 14,229 | 13,350 | 13,632 |
| Cost of revenue | 9,016 | 7,798 | 7,808 | 8,032 | 7,833 | 7,250 | 6,964 | 6,329 | 5,968 | 5,374 | 4,980 | 5,156 |
| Gross profit | 14,646 | 13,631 | 12,867 | 13,323 | 12,443 | 11,847 | 11,719 | 10,746 | 9,462 | 8,855 | 8,370 | 8,476 |
| Selling, general and administrative | 5,234 | 4,729 | 4,420 | 4,527 | 4,264 | 4,063 | 3,861 | 3,547 | 3,275 | 2,926 | 2,761 | 2,773 |
| Operating income | 4,668 | 4,861 | 4,271 | 4,671 | 4,188 | 4,491 | 4,016 | 3,664 | 3,105 | 3,394 | 3,249 | 3,295 |
| EBIT | 4,668 | 4,861 | 4,271 | 4,671 | 4,188 | 4,491 | 4,016 | 3,664 | 3,105 | 3,394 | 3,249 | 3,295 |
| EBITDA | 5,617 | 5,810 | 5,030 | 5,589 | 4,947 | 5,250 | 4,532 | 4,358 | 3,639 | 3,910 | 3,745 | 3,791 |
| Interest expense | 710 | 466 | 597 | 539 | 549 | 389 | 524 | 335 | 239 | 54.0 | 112 | 85.3 |
| Pre-tax income | 4,363 | 4,646 | 3,645 | 4,460 | 4,004 | 4,025 | 3,089 | 3,737 | 3,213 | 3,357 | 3,597 | 3,664 |
| Income tax | 1,134 | 1,224 | 636 | -453 | 925 | 835 | 701 | 919 | 850 | 842 | 703 | 897 |
| Net income | 3,225 | 3,422 | 3,009 | 4,913 | 3,080 | 3,190 | 2,388 | 2,818 | 2,363 | 2,515 | 2,893 | 2,767 |
| Net income to common shareholders | 3,225 | 3,422 | 3,009 | 4,913 | 3,080 | 3,190 | 2,388 | 2,818 | 2,363 | 2,515 | 2,893 | 2,767 |
| Basic EPS | 3.32 | 3.52 | 3.10 | 5.02 | 3.17 | 3.28 | 2.46 | 2.90 | 2.43 | 2.59 | 2.98 | 2.85 |
| Diluted EPS | 3.30 | 3.50 | 3.09 | 5.02 | 3.15 | 3.26 | 2.44 | 2.88 | 2.42 | 2.58 | 2.97 | 2.84 |
| Average shares (basic) | 971 | 972 | 971 | 979 | 972 | 973 | 971 | 972 | 972 | 971 | 971 | 971 |
| Average shares (diluted) | 977 | 978 | 974 | 979 | 978 | 979 | 979 | 979 | 976 | 975 | 974 | 974 |
| Dividend per share | — | 2.00 | — | — | — | 1.50 | — | — | — | 1.50 | — | — |